Skip to main content
Erschienen in: Infection 3/2010

01.06.2010 | Clinical and Epidemiological Study

An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients

verfasst von: T. Mann, D. Ben-David, A. Zlotkin, D. Shachar, N. Keller, A. Toren, A. Nagler, G. Smollan, A. Barzilai, G. Rahav

Erschienen in: Infection | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

Burkholderia cepacia is a common environmental bacterium that is resistant to disinfectants, and therefore is often encountered as a hospital-acquired pathogen. We describe an outbreak of B. cenocepacia bacteremia among hospitalized oncology patients.

Methods

A matched case–control study and an extensive environmental investigation were conducted. Species were identified by RFLP of the amplified recA gene. DNA was fingerprinted by pulsed-field gel electrophoresis (PFGE).

Results

Between November 2005 and September 2006, B. cenocepacia bacteremia developed in 17 patients with underlying malignancy of whom 14 had tunneled central venous catheters. All patients had fever and chills which subsided following removal of the central catheter and administration of ceftazidime. Extensive epidemiological investigation could not find a common source for the outbreak. Patients were hospitalized in three different buildings with different health care personnel. Medications were prepared in different sites by different personnel. A multivariate analysis demonstrated that the independent risk factors for developing nosocomial B. cenocepacia bacteremia were hospitalization at the center for long-term support (OR 28.8; 95% CI 1.83–453.4) and reduced use of antibiotics during the last month (OR 0.07; 95% CI 0.01–0.40). All isolates had identical antimicrobial susceptibility; PFGE indicated that a complex of closely related strains was involved in the outbreak. All isolates were identified as B. cenocepacia, known to infect cystic fibrosis patients. Strict infection control measures terminated the outbreak.

Conclusions

B. cenocepacia is an emerging nosocomial pathogen among oncology patients.
Literatur
1.
Zurück zum Zitat Mortensen JE, Fischer MC, LiPuma JJ. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol. 1995;16:30–2.CrossRefPubMed Mortensen JE, Fischer MC, LiPuma JJ. Recovery of Pseudomonas cepacia and other Pseudomonas species from the environment. Infect Control Hosp Epidemiol. 1995;16:30–2.CrossRefPubMed
2.
Zurück zum Zitat Mahenthiralingam E, Baldwin A, Vandamme P. Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol. 2002;51:533–8.PubMed Mahenthiralingam E, Baldwin A, Vandamme P. Burkholderia cepacia complex infection in patients with cystic fibrosis. J Med Microbiol. 2002;51:533–8.PubMed
3.
Zurück zum Zitat Pegues DA, Carson LA, Anderson RL, Norgard MJ, Argent TA, Jarvis WR, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis. 1993;16:407–11.PubMed Pegues DA, Carson LA, Anderson RL, Norgard MJ, Argent TA, Jarvis WR, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis. 1993;16:407–11.PubMed
4.
Zurück zum Zitat Gravel-Tropper D, Sample ML, Oxley C, Toye B, Woods DE, Garber GE. Three year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol. 1996;17:737–40.CrossRefPubMed Gravel-Tropper D, Sample ML, Oxley C, Toye B, Woods DE, Garber GE. Three year outbreak of pseudobacteremia with Burkholderia cepacia traced to a contaminated blood gas analyzer. Infect Control Hosp Epidemiol. 1996;17:737–40.CrossRefPubMed
5.
Zurück zum Zitat Reboli AC, Koshinski R, Arias K, Marks-Austin K, Stieritz D, Stull TL. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol. 1996;17:741–3.CrossRefPubMed Reboli AC, Koshinski R, Arias K, Marks-Austin K, Stieritz D, Stull TL. An outbreak of Burkholderia cepacia lower respiratory tract infection associated with contaminated albuterol nebulization solution. Infect Control Hosp Epidemiol. 1996;17:741–3.CrossRefPubMed
6.
Zurück zum Zitat van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol. 1998;19:112–3.CrossRefPubMed van Laer F, Raes D, Vandamme P, Lammens C, Sion JP, Vrints C, et al. An outbreak of Burkholderia cepacia with septicemia on a cardiology ward. Infect Control Hosp Epidemiol. 1998;19:112–3.CrossRefPubMed
7.
Zurück zum Zitat Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnauwakul S. An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiologic and molecular study. Am J Kidney Dis. 2000;36:199–204.PubMedCrossRef Kaitwatcharachai C, Silpapojakul K, Jitsurong S, Kalnauwakul S. An outbreak of Burkholderia cepacia bacteremia in hemodialysis patients: an epidemiologic and molecular study. Am J Kidney Dis. 2000;36:199–204.PubMedCrossRef
8.
Zurück zum Zitat Matrician L, Ange G, Burns S, Fanning WL, Kioski C, Cage GD, et al. Outbreak of nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash. Infect Control Hosp Epidemiol. 2000;21:739–41.CrossRefPubMed Matrician L, Ange G, Burns S, Fanning WL, Kioski C, Cage GD, et al. Outbreak of nosocomial Burkholderia cepacia infection and colonization associated with intrinsically contaminated mouthwash. Infect Control Hosp Epidemiol. 2000;21:739–41.CrossRefPubMed
9.
Zurück zum Zitat Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Qaiyumi S, et al. An episodic outbreak of genetically related Burkholderia cepacia among non CF patients at a university hospital. Infect Control Hosp Epidemiol. 2001;22:419–22.CrossRefPubMed Siddiqui AH, Mulligan ME, Mahenthiralingam E, Hebden J, Brewrink J, Qaiyumi S, et al. An episodic outbreak of genetically related Burkholderia cepacia among non CF patients at a university hospital. Infect Control Hosp Epidemiol. 2001;22:419–22.CrossRefPubMed
10.
Zurück zum Zitat Doit C, Loukil C, Simon AM, Ferroni A, Fontan JE, Bonacorsi S, et al. Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers. J Clin Microbiol. 2004;42:2227–30.CrossRefPubMed Doit C, Loukil C, Simon AM, Ferroni A, Fontan JE, Bonacorsi S, et al. Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers. J Clin Microbiol. 2004;42:2227–30.CrossRefPubMed
11.
Zurück zum Zitat Nasser RM, Rahi AC, Haddad MF, Daoud Z, Irani-Hakime N, Almawi WY. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect Control Hosp Epidemiol. 2004;25:231–9.CrossRefPubMed Nasser RM, Rahi AC, Haddad MF, Daoud Z, Irani-Hakime N, Almawi WY. Outbreak of Burkholderia cepacia bacteremia traced to contaminated hospital water used for dilution of an alcohol skin antiseptic. Infect Control Hosp Epidemiol. 2004;25:231–9.CrossRefPubMed
12.
Zurück zum Zitat Shehabi AA, Abu Al Soud W, Mahafzah A, Khuri-Bulos N, Abu Khader I, Ouis IS, et al. Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than CF. Scand J Infect Dis. 2004;36:174–8.CrossRefPubMed Shehabi AA, Abu Al Soud W, Mahafzah A, Khuri-Bulos N, Abu Khader I, Ouis IS, et al. Investigation of Burkholderia cepacia nosocomial outbreak with high fatality in patients suffering from diseases other than CF. Scand J Infect Dis. 2004;36:174–8.CrossRefPubMed
13.
Zurück zum Zitat Souza AV, Moreira CR, Pasternak J, Hirata Mde L, Saltini DA, Caetano VC, et al. Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit. J Med Microbiol. 2004;53:999–1005.CrossRefPubMed Souza AV, Moreira CR, Pasternak J, Hirata Mde L, Saltini DA, Caetano VC, et al. Characterizing uncommon Burkholderia cepacia complex isolates from an outbreak in a haemodialysis unit. J Med Microbiol. 2004;53:999–1005.CrossRefPubMed
14.
Zurück zum Zitat Otağ F, Ersöz G, Salcioğlu M, Bal C, Schneider I, Bauernfeind A. Nosocomial bloodstream infections with Burkholderia stabilis. J Hosp Infect. 2005;59:46–52.CrossRefPubMed Otağ F, Ersöz G, Salcioğlu M, Bal C, Schneider I, Bauernfeind A. Nosocomial bloodstream infections with Burkholderia stabilis. J Hosp Infect. 2005;59:46–52.CrossRefPubMed
15.
Zurück zum Zitat Estivariz CF, Bhatti LI, Pati R, Jensen B, Arduino MJ, Jernigan D, et al. An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest. 2006;130:1346–53.CrossRefPubMed Estivariz CF, Bhatti LI, Pati R, Jensen B, Arduino MJ, Jernigan D, et al. An outbreak of Burkholderia cepacia associated with contamination of albuterol and nasal spray. Chest. 2006;130:1346–53.CrossRefPubMed
16.
Zurück zum Zitat Held MR, Begier EM, Beardsley DS, Browne FA, Martinello RA, Baltimore RS, et al. Life threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state. Pediatrics. 2006;118:e212–5.CrossRefPubMed Held MR, Begier EM, Beardsley DS, Browne FA, Martinello RA, Baltimore RS, et al. Life threatening sepsis caused by Burkholderia cepacia from contaminated intravenous flush solutions prepared by a compounding pharmacy in another state. Pediatrics. 2006;118:e212–5.CrossRefPubMed
17.
Zurück zum Zitat Lo Cascio G, Bonora MG, Zorazi A, Mortani E, Tessitore N, Loschiavo C, et al. A napkin associated outbreak of Burkholderia cenocepacia bacteremia in hemodialysis patients. J Hosp Infect. 2006;64:56–62.CrossRefPubMed Lo Cascio G, Bonora MG, Zorazi A, Mortani E, Tessitore N, Loschiavo C, et al. A napkin associated outbreak of Burkholderia cenocepacia bacteremia in hemodialysis patients. J Hosp Infect. 2006;64:56–62.CrossRefPubMed
18.
Zurück zum Zitat Abe K, D’Angelo MT, Sunenshine R, Noble-Wang J, Cope J, Jensen B, et al. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice. Infect Control Hosp Epidemiol. 2007;28:1311–3.CrossRefPubMed Abe K, D’Angelo MT, Sunenshine R, Noble-Wang J, Cope J, Jensen B, et al. Outbreak of Burkholderia cepacia bloodstream infection at an outpatient hematology and oncology practice. Infect Control Hosp Epidemiol. 2007;28:1311–3.CrossRefPubMed
19.
Zurück zum Zitat Heo ST, Kim S, Jeong YG, Bae IG, Jin JS, Lee JC. Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters. J Hosp Infect. 2008;70:241–5.CrossRefPubMed Heo ST, Kim S, Jeong YG, Bae IG, Jin JS, Lee JC. Hospital outbreak of Burkholderia stabilis bacteraemia related to contaminated chlorhexidine in haematological malignancy patients with indwelling catheters. J Hosp Infect. 2008;70:241–5.CrossRefPubMed
20.
Zurück zum Zitat Romero-Gómez MP, Quiles-Melero MI, Peña García P, Gutiérrez Altes A, García de Miguel MA, Jiménez C, et al. Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect Control Hosp Epidemiol. 2008;29:377–8.CrossRefPubMed Romero-Gómez MP, Quiles-Melero MI, Peña García P, Gutiérrez Altes A, García de Miguel MA, Jiménez C, et al. Outbreak of Burkholderia cepacia bacteremia caused by contaminated chlorhexidine in a hemodialysis unit. Infect Control Hosp Epidemiol. 2008;29:377–8.CrossRefPubMed
21.
Zurück zum Zitat Yu WL, Wang DY, Lin CW, Tsou MF. Endemic Burkholderia cepacia bacteremia: clinical features and antimicrobial susceptibilities of isolates. Scand J Infect Dis. 1999;31:293–8.CrossRefPubMed Yu WL, Wang DY, Lin CW, Tsou MF. Endemic Burkholderia cepacia bacteremia: clinical features and antimicrobial susceptibilities of isolates. Scand J Infect Dis. 1999;31:293–8.CrossRefPubMed
22.
Zurück zum Zitat Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW. Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect. 2001;34:215–9.PubMed Huang CH, Jang TN, Liu CY, Fung CP, Yu KW, Wong WW. Characteristics of patients with Burkholderia cepacia bacteremia. J Microbiol Immunol Infect. 2001;34:215–9.PubMed
23.
Zurück zum Zitat Bressler AM, Kaye KS, LiPuma JJ, Alexander BD, Moore CM, Reller LB, et al. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. Infect Control Hosp Epidemiol. 2007;28:951–8.CrossRefPubMed Bressler AM, Kaye KS, LiPuma JJ, Alexander BD, Moore CM, Reller LB, et al. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case-control study. Infect Control Hosp Epidemiol. 2007;28:951–8.CrossRefPubMed
24.
Zurück zum Zitat Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries. 2009;3:273–7.PubMed Dizbay M, Tunccan OG, Sezer BE, Aktas F, Arman D. Nosocomial Burkholderia cepacia infections in a Turkish university hospital: a five-year surveillance. J Infect Dev Ctries. 2009;3:273–7.PubMed
25.
Zurück zum Zitat Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. 2008;14:378–84.CrossRefPubMed Levy I, Grisaru-Soen G, Lerner-Geva L, Kerem E, Blau H, Bentur L, et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis. 2008;14:378–84.CrossRefPubMed
26.
Zurück zum Zitat Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165–73.PubMed Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, et al. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol. 2000;38:3165–73.PubMed
27.
Zurück zum Zitat Coenye T, Vandamme P, Govan JR, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39:3427–36.CrossRefPubMed Coenye T, Vandamme P, Govan JR, LiPuma JJ. Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol. 2001;39:3427–36.CrossRefPubMed
28.
Zurück zum Zitat LiPuma JJ, Spilker T, Gill L, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med. 2001;164:92–6.PubMed LiPuma JJ, Spilker T, Gill L, Campbell PW, Liu L, Mahenthiralingam E. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am J Respir Crit Care Med. 2001;164:92–6.PubMed
29.
Zurück zum Zitat Reik R, Spilker T, LiPuma JJ. Distribution of Burkholderia cepacia complex species recovered from persons with or without cystic fibrosis. J Clin Microbiol. 2005;43:2926–8.CrossRefPubMed Reik R, Spilker T, LiPuma JJ. Distribution of Burkholderia cepacia complex species recovered from persons with or without cystic fibrosis. J Clin Microbiol. 2005;43:2926–8.CrossRefPubMed
30.
Zurück zum Zitat Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009;31:146–50.CrossRefPubMed Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009;31:146–50.CrossRefPubMed
31.
Zurück zum Zitat Isenberg HD, editor. Clinical microbiology procedures handbook. Epidemiologic and infection control microbiology. Vol. 3, sect. 13.10.1, 2nd ed. ASM Press, Washington, D.C., 2004. Isenberg HD, editor. Clinical microbiology procedures handbook. Epidemiologic and infection control microbiology. Vol. 3, sect. 13.10.1, 2nd ed. ASM Press, Washington, D.C., 2004.
32.
Zurück zum Zitat Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: Sixteenth informational supplement M100-S16. 2006. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. In: Sixteenth informational supplement M100-S16. 2006.
33.
Zurück zum Zitat Mahenthiralingam E, Coenye T, Chung J, Speert DP, Govan JRW, Taylor P, et al. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol. 2000;38:910–3.PubMed Mahenthiralingam E, Coenye T, Chung J, Speert DP, Govan JRW, Taylor P, et al. Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex. J Clin Microbiol. 2000;38:910–3.PubMed
34.
Zurück zum Zitat Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMed Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMed
35.
Zurück zum Zitat Millar-Jones L, Paull A, Saunders Z, Goodchild MC. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet. 1992;340:491.CrossRefPubMed Millar-Jones L, Paull A, Saunders Z, Goodchild MC. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet. 1992;340:491.CrossRefPubMed
36.
Zurück zum Zitat Pegues DA, Carson LA, Tablan OC, FitzSimmons SC, Roman SB, Miller JM, et al. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr. 1994;124:694–702.CrossRefPubMed Pegues DA, Carson LA, Tablan OC, FitzSimmons SC, Roman SB, Miller JM, et al. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. Summer Camp Study Group. J Pediatr. 1994;124:694–702.CrossRefPubMed
37.
Zurück zum Zitat Vermis K, Brachkova M, Vandamme P, Nelis H. Isolation of Burkholderia cepacia complex genomovars from waters. Syst Appl Microbiol. 2003;26:595–600.CrossRefPubMed Vermis K, Brachkova M, Vandamme P, Nelis H. Isolation of Burkholderia cepacia complex genomovars from waters. Syst Appl Microbiol. 2003;26:595–600.CrossRefPubMed
38.
Zurück zum Zitat Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by random amplified polymorphic DNA (RAPD) fingerprinting. J Clin Microbiol. 1996;34:2914–20.PubMed Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by random amplified polymorphic DNA (RAPD) fingerprinting. J Clin Microbiol. 1996;34:2914–20.PubMed
39.
Zurück zum Zitat Vermis K, Coenye T, Mahenthiralingam E, Nelis HJ, Vandamme P. Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J Med Microbiol. 2002;51:937–40.PubMed Vermis K, Coenye T, Mahenthiralingam E, Nelis HJ, Vandamme P. Evaluation of species-specific recA-based PCR tests for genomovar level identification within the Burkholderia cepacia complex. J Med Microbiol. 2002;51:937–40.PubMed
40.
Zurück zum Zitat Payne GW, Vandamme P, Morgan SH, Lipuma JJ, Coenye T, Weightman AJ, et al. Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol. 2005;71:3917–27.CrossRefPubMed Payne GW, Vandamme P, Morgan SH, Lipuma JJ, Coenye T, Weightman AJ, et al. Development of a recA gene-based identification approach for the entire Burkholderia genus. Appl Environ Microbiol. 2005;71:3917–27.CrossRefPubMed
41.
Zurück zum Zitat Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol. 2005;43:4665–73.CrossRefPubMed Baldwin A, Mahenthiralingam E, Thickett KM, Honeybourne D, Maiden MC, Govan JR, et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol. 2005;43:4665–73.CrossRefPubMed
42.
Zurück zum Zitat Cesarini S, Bevivino A, Tabacchioni S, Chiarini L, Dalmastri C. RecA gene sequence and multilocus sequence typing for species-level resolution of Burkholderia cepacia complex isolates. Lett Appl Microbiol. 2009;49:580–8.CrossRefPubMed Cesarini S, Bevivino A, Tabacchioni S, Chiarini L, Dalmastri C. RecA gene sequence and multilocus sequence typing for species-level resolution of Burkholderia cepacia complex isolates. Lett Appl Microbiol. 2009;49:580–8.CrossRefPubMed
43.
Zurück zum Zitat Turton JF, Arif N, Hennessy D, Kaufmann ME, Pitt TL. Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars. J Clin Microbiol. 2007;45:3105–8.CrossRefPubMed Turton JF, Arif N, Hennessy D, Kaufmann ME, Pitt TL. Revised approach for identification of isolates within the Burkholderia cepacia complex and description of clinical isolates not assigned to any of the known genomovars. J Clin Microbiol. 2007;45:3105–8.CrossRefPubMed
44.
Zurück zum Zitat Graindorge A, Menard A, Neto M, Bouvet C, Miollan R, Gaillard S, et al. Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. Diagn Microbiol Infect Dis. 2010;66:29–40.CrossRefPubMed Graindorge A, Menard A, Neto M, Bouvet C, Miollan R, Gaillard S, et al. Epidemiology and molecular characterization of a clone of Burkholderia cenocepacia responsible for nosocomial pulmonary tract infections in a French intensive care unit. Diagn Microbiol Infect Dis. 2010;66:29–40.CrossRefPubMed
45.
46.
Zurück zum Zitat LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med. 1998;4:337–41.CrossRefPubMed LiPuma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulm Med. 1998;4:337–41.CrossRefPubMed
47.
Zurück zum Zitat Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53–80.CrossRefPubMed Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:53–80.CrossRefPubMed
48.
Zurück zum Zitat Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986;134:669–71.PubMed Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis. 1986;134:669–71.PubMed
Metadaten
Titel
An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients
verfasst von
T. Mann
D. Ben-David
A. Zlotkin
D. Shachar
N. Keller
A. Toren
A. Nagler
G. Smollan
A. Barzilai
G. Rahav
Publikationsdatum
01.06.2010
Verlag
Urban and Vogel
Erschienen in
Infection / Ausgabe 3/2010
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-010-0017-0

Weitere Artikel der Ausgabe 3/2010

Infection 3/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.